| Literature DB >> 28182785 |
Nicolas Bruffaerts1, Christelle Vluggen2, Virginie Roupie3, Lucille Duytschaever3,4, Christophe Van den Poel1, Joseph Denoël4, Ruddy Wattiez5, Jean-Jacques Letesson6, David Fretin3, Leen Rigouts7,8, Ophélie Chapeira9, Vanessa Mathys2, Claude Saegerman4, Kris Huygen1.
Abstract
Mycobacterium avium subsp. hominissuis (Mah) represents a health concern for humans and to a lesser extent for pigs, but its zoonotic potential remains elusive. Using multispacer sequence typing (MST) we previously identified 49 different genotypes of Mah among Belgian clinical and porcine isolates, with 5 MSTs shared by both hosts. Using experimental intranasal infection of BALB/c mice, we compared the virulence and immunogenicity of porcine and clinical human isolates with shared genotype or with a genotype only found in humans or pigs. Bacterial replication was monitored for 20 weeks in lungs, spleen and liver and mycobacteria specific spleen cell IFN-γ, IL-10 and IL-17 production as well as serum antibody responses were analyzed. Isolates varied in virulence, with human and porcine isolates sharing MST22 genotype showing a thousand fold higher bacterial replication in lungs and more dissemination to spleen and liver than the human and porcine MST91 isolates. Virulent MST22 type was also associated with progressive suppression of IFN-γ and IL-17 responses, and increased IL-10 production. Whole genome sequencing of the two virulent isolates with MST22 genotype and two avirulent isolates of genotype MST91 and comparison with two well-studied M. avium subsp. hominissuis reference strains i.e. Mah 104 and Mah TH135, identified in the two MST22 isolates nine specific virulence factors of the mammalian cell entry family, that were identical with Mah 104 strain. Despite the obvious limitations of the mouse model, a striking link of virulence and identity at the genome level of porcine and human isolates with the same multisequence type, for which no correlation of place of residence (humans) or farm of origin (pigs) was observed, seems to point to the existence in the environment of certain genotypes of Mah which may be more infectious both for humans and pigs than other genotypes.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28182785 PMCID: PMC5300754 DOI: 10.1371/journal.pone.0171895
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
List of the porcine and human M. avium subsp. hominissuis isolates used in this study.
| Isolate name | MST code | Ref. name in [ | Age | Sex | Symptoms |
| Hu | 12 | 12_009 | Unknown | Female | Unknown |
| Hu | 15 | 12MY0204 | 4 years | Female | Lymphadenitis |
| Hu | 22 | 12_062 | 40 years | Male | HIV neg, disseminated |
| Hu | 91 | 12_067 | 40 years | Male | AIDS, disseminated |
| Isolate name | MST code | Ref. name in [ | Symptoms | ||
| Po | 12 | LYM108 | Mandibular lymphadenitis | ||
| Po | 22 | LYM122 | Mandibular lymphadenitis | ||
| Po | 91 | LYM86 | Mandibular lymphadenitis | ||
| Po | 103 | LYM119 | Mandibular lymphadenitis | ||
List of 35 recombinant M. avium subsp. paratuberculosis antigens.
| Description | E value | Ident. | Accession | Myco | ||
|---|---|---|---|---|---|---|
| 1 | transcriptional regulator, PadR family protein [Mycobacterium avium 104] | 8,00E-144 | 99% | ABK65696.1 | ||
| 2 | transglycosylase SLT domain protein [Mycobacterium avium 104] | 0 | 99% | ABK65241.1 | ||
| 3 | morphine 6-dehydrogenase [Mycobacterium avium 104] | 0 | 98% | ABK68334.1 | ||
| oxidoreductase [Mycobacterium avium subsp. hominissuis TH135] | 1,00E-52 | 41% | BAN32966.1 | |||
| 4 | alpha/beta hydrolase fold domain protein [Mycobacterium avium 104] | 0 | 99% | ABK65668.1 | ||
| alpha/beta hydrolase [Mycobacterium avium subsp. hominissuis TH135] | 2,00E-24 | 40% | BAN33440.1 | |||
| 5 | conserved hypothetical protein [Mycobacterium avium 104] | 1,00E-89 | 100% | ABK66813.1 | ||
| 6 | peptidyl-prolyl cis-trans isomerase, fkbp-type domain protein [Mycobacterium avium 104] | 1,00E-125 | 98% | ABK64725.1 | ||
| peptidyl-prolyl cis-trans isomerase domain-containing protein [Mycobacterium avium subsp. hominissuis TH135] | 4,00E-113 | 100% | BAN31629.1 | |||
| 7 | pyridoxamine 5-phosphate oxidase [Mycobacterium avium subsp. hominissuis 10–4249] | 9,00E-101 | 100% | ETB30907.1 | ||
| 8 | glyoxalase family protein [Mycobacterium avium 104] | 8,00E-92 | 98% | ABK69112.1 | ||
| 9 | hypothetical protein MAH_1788 [Mycobacterium avium subsp. hominissuis TH135] | 4,00E-119 | 98% | BAN30862.1 | ||
| conserved hypothetical protein [Mycobacterium avium 104] | 2,00E-109 | 99% | ABK64828.1 | |||
| 10 | integral membrane protein YrbE1A [Mycobacterium avium subsp. hominissuis TH135] | 3,4 | 20% | BAN33502.1 | ||
| conserved hypothetical protein [Mycobacterium avium 104] | 3,4 | 20% | ABK66937.1 | |||
| 11 | methyltransferase [Mycobacterium avium subsp. hominissuis TH135] | 8,00E-65 | 64% | BAN32924.1 | ||
| hypothetical protein MAH_3962 [Mycobacterium avium subsp. hominissuis TH135] | 2,00E-64 | 44% | BAN33036.1 | |||
| methyltransferase, putative, family protein [Mycobacterium avium 104] | 5,00E-32 | 40% | ABK67089.1 | |||
| 12 | lactate 2-monooxygenase [Mycobacterium avium 104] | 0 | 99% | ABK65670.1 | ||
| LldD2 protein [Mycobacterium avium subsp. hominissuis TH135] | 4,00E-35 | 32% | BAN31520.1 | |||
| 13 | hypothetical protein MAV3388_23345 [Mycobacterium avium subsp. hominissuis 3388] | 0 | 99% | KDO92449.1 | ||
| conserved hypothetical protein [Mycobacterium avium 104] | 2,00E-17 | 26% | ABK65078.1 | |||
| 14 | Formate dehydrogenase [Mycobacterium avium subsp. hominissuis TH135] | 0 | 99% | BAN33415.1 | ||
| formate dehydrogenase [Mycobacterium avium 104] | 0 | 99% | ABK68013.1 | |||
| 15 | O-antigen export system ATP-binding protein RfbB [Mycobacterium avium 104] | 0,13 | 21% | ABK65477.1 | ||
| O-antigen export system ATP-binding protein RfbB [Mycobacterium avium subsp. hominissuis TH135] | 0,16 | 21% | BAN29326.1 | |||
| 16 | glycosyl hydrolases family protein 16 [Mycobacterium avium 104] | 0 | 100% | ABK67366.1 | ||
| glycosyl hydrolases family protein 16 [Mycobacterium avium subsp. hominissuis TH135] | 7,00E-174 | 100% | BAN33331.1 | |||
| 17 | nitroreductase family protein [Mycobacterium avium 104] | 6,00E-115 | 99% | ABK64565.1 | ||
| nitroreductase [Mycobacterium avium subsp. hominissuis TH135] | 2,00E-04 | 23% | BAN29848.1 | |||
| 18 | fructose-bisphosphate aldolase class-I [Mycobacterium avium 104] | 0 | 99% | ABK68800.1 | ||
| 19 | hypothetical protein MAPs_16490 [Mycobacterium avium subsp. paratuberculosis S397] | 2,00E-166 | 100% | |||
| 20 | MULTISPECIES: ATP-dependent helicase [Mycobacterium avium complex (MAC) | 0,047 | 39% | |||
| 21 | M. avium UbD family decarboxylase | 0,00E+00 | 99% | WP_016706304.1 | ||
| 22 | hypothetical protein MAP_0388 [Mycobacterium avium subsp. paratuberculosis K-10] | 0 | 99% | |||
| 23 | hypothetical protein MAP_3743 [Mycobacterium avium subsp. paratuberculosis K-10] | 0 | 99% | |||
| 24 | thiazolinyl imide reductase [Mycobacterium avium subsp. paratuberculosis 10–4404] | 0 | 99% | |||
| 24 | thiazolinyl imide reductase [Mycobacterium avium] | 0 | 99% | |||
| 25 | antigen 85-C [Mycobacterium avium 104] | 7,00E-180 | 99% | ABK64781.1 | ||
| antigen 85-C protein [Mycobacterium avium subsp. hominissuis TH135] | 3,00E-179 | 99% | BAN29303.1 | |||
| 26 | glycerol kinase [Mycobacterium avium 104] | 0 | 99% | ABK67587.1 | ||
| 27 | RecName: Full = Triosephosphate isomerase; Short = TIM; Short = TPI; AltName: Full = Triose-phosphate isomerase | 0 | 99% | A0QHY3.1 | ||
| 28 | arginine biosynthesis bifunctional protein ArgJ [Mycobacterium avium 104] | 9,00E-145 | 99% | ABK65024.1 | ||
| 29 | dienelactone hydrolase [Mycobacterium avium subsp. hominissuis TH135] | 4,00E-166 | 99% | BAN31765.1 | ||
| dienelactone hydrolase family protein [Mycobacterium avium 104] | 2,00E-143 | 99% | ABK69268.1 | |||
| 30 | enoyl-CoA hydratase [Mycobacterium avium 104] | 0 | 99% | ABK64508.1 | ||
| enoyl-CoA hydratase [Mycobacterium avium subsp. hominissuis TH135] | 2,00E-24 | 30% | BAN30137.1 | |||
| 31 | dihydrodipicolinate synthase [Mycobacterium avium 104] | 0 | 99% | ABK66322.1 | ||
| 32 | aldehyde dehydrogenase (NAD) family protein [Mycobacterium avium 104] | 0 | 99% | ABK69290.1 | ||
| P-cumic aldehyde dehydrogenase [Mycobacterium avium subsp. hominissuis TH135] | 3,00E-41 | 27% | BAN31590.1 | |||
| 33 | ErfK/YbiS/YcfS/YnhG family protein [Mycobacterium avium 104]Lipoprotein lprQ | 0 | 100% | ABK64614.1 | ||
| hypothetical protein MAH_1464 [Mycobacterium avium subsp. hominissuis TH135] | 6,00E-48 | 41% | BAN30538.1 | |||
| 34 | phosphotriesterase-like protein [Mycobacterium avium subsp. hominissuis TH135] | 0 | 99% | BAN33426.1 | ||
| phosphotriesterase-like protein [Mycobacterium avium 104] | 0 | 99% | ABK64738.1 | |||
| 35 | Malate dehydrogenase | 0 | 99% | A0QCI6.1 |
Ags 1–18: Map antigens identified by proteomic and immunoproteomic analysis of Map culture filtrate [26]; Ags 19–24: Map antigens identified by in silico predictions [27]; Ags 25–35: Map antigens identified in Map cultures submitted to stress conditions: nutrient starvation, hypoxia or acidic pH (Roupie et al., manuscript in preparation). Proteins actually upregulated in stress conditions are highlighted in grey. Putative function and results of BlastP comparison (E value and % protein identity) with Mah104 and Mah TH135 genome.
Fig 1Bacterial replication in lungs (A), spleen (B) and liver (C) of BALB/c mice infected with one of the eight Data represent mean CFU (log10)/organ ± SEM of five animals tested per group. Isolate IDs represent the host (Hu: human; Po: swine) followed by the respective multispacer sequence type (MST). Statistical significance is depicted for each strain as compared to both Po91 and Hu91 (*: p<0.05).
Fig 2Spleen cell IFN-γ production in response to M. avium culture filtrate (5 μg/mL) in BALB/c mice infected for 5 weeks (filled bars) or 20 weeks (striped bars) with the different Mah isolates.
Results represent mean IFN-γ levels (pg/mL) ± SEM of 3–5 mice tested individually. Statistical significance is depicted for each human or porcine strain as compared to respectively Hu91 or Po91 (*: p<0.05). N.A.: not available.
Fig 3IFN-γ (A), IL-10 (B) and IL-17 (C) production in 72h spleen cell culture supernatant of mice infected for 20 weeks with human and porcine MST22 (red) and human or porcine MST91 (green) Cells were unstimulated (filled bars) or stimulated with culture filtrate (striped bars). Results represent mean cytokine levels (pg/mL) ± SEM of 5 mice tested individually in each group. Statistical significance is depicted for MST22 strains as compared to MST91 strains (*: p<0.05; **: p<0.005; n.s.: non-significant).
Fig 4IFN-γ response of BALB/c mice infected intranasally with porcine MST12 isolate (Po12).
Mice (n = 5) were sacrificed 5 weeks post-infection and pooled spleen cells were stimulated for 72h with each of the 35 Map antigens (5 μg/mL). IFN-γ levels are expressed in pg/mL.
Fig 5A: IgG antibodies against M. avium culture filtrate in serial dilutions of pooled sera of BALB/c mice infected for 20 weeks with porcine (blue circles) or human (blue squares) Mah MST12 isolate (pooled sera from naïve mice represented by black dots). B: Plate organization and Western blot image of immunoblot of week 20 pooled Mah Po12 serum tested against the 35 Map antigens. Numbers of the two antigens giving the strongest signals are indicated in blue, numbers of the five antigens giving weaker signals are indicated in red.
Genes present at 100% identity in the sequenced Mah strains.
| Gene sequence name | Predicted protein | Presence in Hu | Presence in Po | Presence in Hu | Presence in Po |
| MAH_1657 | PPE | X | X | ||
| Gene sequence name | Predicted protein | Presence in Hu | Presence in Po | Presence in Hu | Presence in Po |
| MAV_RS00575/MAV_0117 | PE | X | X | ||
| MAV_RS04540/MAV_0948 | Mce | X | X | ||
| MAV_RS04550/MAV_0950 | Mce | X | X | ||
| MAV_RS04555/MAV_0951 | Mce | X | X | ||
| MAV_RS04565/MAV_0953 | Mce | X | X | ||
| MAV_RS06460/MAV_1347 | PPE | X | X | ||
| MAV_RS24220/MAV_5047 | SR-21 Mce | X | X | ||
| MAV_RS24225/MAV_5048 | SR-21 Mce | X | X | ||
| MAV_RS24230/MAV_5049 | SR-21 Mce | X | X | ||
| MAV_RS24240/MAV_5051 | SR-21 Mce | X | X | ||
| MAV_RS24245/MAV_5052 | SR-21 Mce | X | X | ||